Mexican Drugmaker Warned for Adulterated Product

Drug Industry Daily
A A
The FDA issued a warning letter to Prosana Distribuciones in Mexico City for serious GMP violations and for producing an adulterated drug product.

To View This Article:

Login

Subscribe To Drug Industry Daily